Method and compounds for use in the treatment of steroid induced states of the central nervous system
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 24, 2002
Issued Date -
N/A
app pub date -
Mar 11, 1999
filing date -
Mar 11, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The use of epiallopregnanolone (3.beta.-hydroxy-5.alpha.-pregnan-20-one) for the treatment of steroid induced mood disorders and CNS disorders is disclosed. Further, the use of epiallopregnanolone for the manufacture of pharmaceuticals is disclosed, together with an list of symptoms suitable for treatment with epiallopregnanolone.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully